Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bas Groot Koerkamp

Showing results (181-190 of 486) with videos related to

Pageof 49
Sort By:
Journal of Surgical Oncology|February 15, 2017
Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinomaGaya Spolverato, Fabio Bagante, Matthew Weiss, et al.
Journal of the American College of Surgeons|July 9, 2017
Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein EmbolizationPim B Olthof, Jimme K Wiggers, Bas Groot Koerkamp, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 30, 2017
Conditional survival in patients with unresectable perihilar cholangiocarcinomaMarcia P Gaspersz, Stefan Buettner, Jeroen L A van Vugt, et al.
Annals of Surgical Oncology|July 11, 2020
Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump ChemotherapyFlorian E Buisman, Wills F Filipe, Nancy E Kemeny, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 29, 2020
Should jaundice preclude resection in patients with gallbladder cancer? Results from a nation-wide cohort studyElise A J de Savornin Lohman, Hendrien Kuipers, Mike van Dooren, et al.
Pancreas|October 29, 2021
Resection of the Portal-Superior Mesenteric Vein in Pancreatic Cancer: Pathological Assessment and Recurrence PatternsJesse V Groen, Labrinus van Manen, Stijn van Roessel, et al.
Surgery|December 2, 2025
Survival benefit of adjuvant chemotherapy for perihilar cholangiocarcinoma: Impact of log odds of metastatic lymph node countJun Kawashima, Miho Akabane, Odysseas P Chatzipanagiotou, et al.
BJS Open|March 23, 2026
Clinical implications of an intraoperative margin-positive distal bile duct in perihilar cholangiocarcinoma: international multicentre cohort studyHasan Ahmad Al-Saffar, Britte H E A Ten Haaft, Rebecca Marino, et al.
BMJ Open|October 18, 2018
Protocol for the STRONG trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma, a phase I feasibility studyMerel S Koedijk, Ben J M Heijmen, Bas Groot Koerkamp, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 1, 2024
The tumor immune microenvironment in resected treatment-naive pancreatic cancer patients with long-term survivalCasper W F van Eijck, Jie Ju, Freek R van 't Land, et al.
Pageof 49

Showing results (181-190 of 486) with videos related to

Sort By:
Pageof 49
Journal of Surgical Oncology|February 15, 2017
Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinomaGaya Spolverato, Fabio Bagante, Matthew Weiss, et al.
Journal of the American College of Surgeons|July 9, 2017
Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein EmbolizationPim B Olthof, Jimme K Wiggers, Bas Groot Koerkamp, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 30, 2017
Conditional survival in patients with unresectable perihilar cholangiocarcinomaMarcia P Gaspersz, Stefan Buettner, Jeroen L A van Vugt, et al.
Annals of Surgical Oncology|July 11, 2020
Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump ChemotherapyFlorian E Buisman, Wills F Filipe, Nancy E Kemeny, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 29, 2020
Should jaundice preclude resection in patients with gallbladder cancer? Results from a nation-wide cohort studyElise A J de Savornin Lohman, Hendrien Kuipers, Mike van Dooren, et al.
Pancreas|October 29, 2021
Resection of the Portal-Superior Mesenteric Vein in Pancreatic Cancer: Pathological Assessment and Recurrence PatternsJesse V Groen, Labrinus van Manen, Stijn van Roessel, et al.
Surgery|December 2, 2025
Survival benefit of adjuvant chemotherapy for perihilar cholangiocarcinoma: Impact of log odds of metastatic lymph node countJun Kawashima, Miho Akabane, Odysseas P Chatzipanagiotou, et al.
BJS Open|March 23, 2026
Clinical implications of an intraoperative margin-positive distal bile duct in perihilar cholangiocarcinoma: international multicentre cohort studyHasan Ahmad Al-Saffar, Britte H E A Ten Haaft, Rebecca Marino, et al.
BMJ Open|October 18, 2018
Protocol for the STRONG trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma, a phase I feasibility studyMerel S Koedijk, Ben J M Heijmen, Bas Groot Koerkamp, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 1, 2024
The tumor immune microenvironment in resected treatment-naive pancreatic cancer patients with long-term survivalCasper W F van Eijck, Jie Ju, Freek R van 't Land, et al.
Pageof 49